In a report released today, Amit Hazan from Citigroup maintained a Hold rating on Stryker Corporation (NYSE: SYK), with a price target of $171. The company’s shares opened today at $169.32, close to its 52-week high of $171.35.
According to TipRanks.com, Hazan is a 4-star analyst with an average return of 9.6% and a 57.6% success rate. Hazan covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Baxter International, and Intuitive Surgical.
Currently, the analyst consensus on Stryker Corporation is Moderate Buy and the average price target is $177.13, representing a 4.6% upside.
In a report issued on April 26, Cantor Fitzgerald also maintained a Hold rating on the stock with a $170 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $171.35 and a one-year low of $132.44. Currently, Stryker Corporation has an average volume of 1.29M.
Based on the recent corporate insider activity of 67 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems.
